Harrow Health Stock Performance

HROW Stock  USD 47.20  0.01  0.02%   
On a scale of 0 to 100, Harrow Health holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of 2.47, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Harrow Health will likely underperform. Please check Harrow Health's potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to make a quick decision on whether Harrow Health's current trending patterns will revert.

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Harrow Health are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Harrow Health showed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
5.1
Five Day Return
11.27
Year To Date Return
(5.45)
Ten Year Return
745.7
All Time Return
84.26
Last Split Factor
1:5
Last Split Date
2013-02-08
1
Will Harrows Return to Profitability Reshape Its Growth Narrative
11/19/2025
2
Precision Trading with Harrow Health Inc. 11.875 percent Senior Notes Due 2027 Risk Zones - news.stocktradersdaily.com
12/09/2025
3
Disposition of 180000 shares by Baum Mark L of Harrow Health at 3.95 subject to Rule 16b-3
12/12/2025
4
Understanding the Setup and Scalable Risk - Stock Traders Daily
12/31/2025
5
Disposition of 20000 shares by Opaleye Management Inc. of Harrow Health at 53.3457 subject to Rule 16b-3
01/06/2026
6
Harrow Health stock hits 52-week high at 54.85 USD By Investing.com - Investing.com India
01/07/2026
7
Acquisition by Baum Mark L of 15400 shares of Harrow Health at 7.71 subject to Rule 16b-3
01/08/2026
8
Harrow Flirting With Missing 2025 Revised Guidance - Seeking Alpha
01/12/2026
9
Heres What Could Help Harrow Maintain Its Recent Price Strength
01/15/2026
10
President Trump Releases Video as Part of Hillsdale College The Story of America Series
01/21/2026
11
Insider Trading
01/30/2026
12
OSRX Confirms Ongoing Licensing and Availability of Compounded Ophthalmic Medications in California
02/03/2026
Begin Period Cash Flow74.1 M
Total Cashflows From Investing Activities-33.2 M

Harrow Health Relative Risk vs. Return Landscape

If you would invest  3,444  in Harrow Health on November 6, 2025 and sell it today you would earn a total of  1,275  from holding Harrow Health or generate 37.02% return on investment over 90 days. Harrow Health is currently generating 0.5981% in daily expected returns and assumes 4.0987% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Harrow, and 88% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Harrow Health is expected to generate 5.49 times more return on investment than the market. However, the company is 5.49 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Harrow Health Target Price Odds to finish over Current Price

The tendency of Harrow Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 47.20 90 days 47.20 
about 27.5
Based on a normal probability distribution, the odds of Harrow Health to move above the current price in 90 days from now is about 27.5 (This Harrow Health probability density function shows the probability of Harrow Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.47 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Harrow Health will likely underperform. Additionally Harrow Health has an alpha of 0.3399, implying that it can generate a 0.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Harrow Health Price Density   
       Price  

Predictive Modules for Harrow Health

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Harrow Health. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
44.0048.1052.20
Details
Intrinsic
Valuation
LowRealHigh
42.4755.1759.27
Details
Naive
Forecast
LowNextHigh
43.5047.6051.70
Details
5 Analysts
Consensus
LowTargetHigh
64.2770.6278.39
Details

Harrow Health Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Harrow Health is not an exception. The market had few large corrections towards the Harrow Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Harrow Health, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Harrow Health within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.34
β
Beta against Dow Jones2.47
σ
Overall volatility
5.27
Ir
Information ratio 0.10

Harrow Health Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Harrow Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Harrow Health can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Harrow Health appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 199.61 M. Net Loss for the year was (17.48 M) with profit before overhead, payroll, taxes, and interest of 186.44 M.
Harrow Health currently holds about 51.7 M in cash with (22.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91.
Harrow Health has a very weak financial position based on the latest SEC disclosures
Roughly 59.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: OSRX Confirms Ongoing Licensing and Availability of Compounded Ophthalmic Medications in California

Harrow Health Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Harrow Stock often depends not only on the future outlook of the current and potential Harrow Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Harrow Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding35.7 M
Cash And Short Term Investments47.2 M

Harrow Health Fundamentals Growth

Harrow Stock prices reflect investors' perceptions of the future prospects and financial health of Harrow Health, and Harrow Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Harrow Stock performance.

About Harrow Health Performance

Evaluating Harrow Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Harrow Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Harrow Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 91.22  92.30 
Return On Tangible Assets(0.08)(0.08)
Return On Capital Employed 0.03  0.03 
Return On Assets(0.04)(0.04)
Return On Equity(0.23)(0.24)

Things to note about Harrow Health performance evaluation

Checking the ongoing alerts about Harrow Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Harrow Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Harrow Health appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 199.61 M. Net Loss for the year was (17.48 M) with profit before overhead, payroll, taxes, and interest of 186.44 M.
Harrow Health currently holds about 51.7 M in cash with (22.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91.
Harrow Health has a very weak financial position based on the latest SEC disclosures
Roughly 59.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: OSRX Confirms Ongoing Licensing and Availability of Compounded Ophthalmic Medications in California
Evaluating Harrow Health's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Harrow Health's stock performance include:
  • Analyzing Harrow Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Harrow Health's stock is overvalued or undervalued compared to its peers.
  • Examining Harrow Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Harrow Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Harrow Health's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Harrow Health's stock. These opinions can provide insight into Harrow Health's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Harrow Health's stock performance is not an exact science, and many factors can impact Harrow Health's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.